Bill Gates is speaking out about his personal experience with Alzheimer’s — and his hope for progress in fighting the disease. In an essay published this week on his blog at GatesNotes.com ...

Over time, these fibrils accumulate into plaques which are the pathological hallmarks of more than 50 neurodegenerative diseases, and most notably play a critical central role in Alzheimer's disease.

New Alzheimer's treatment uses CAR T-cell tech to target brain plaques, offering a precise approach with fewer side effects than current drugs.

(Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer’s.) Bill Gates Jr. (right) poses with his father at his graduation ceremony in 1973.

(Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer’s.) "I’m optimistic that these tests will be a game-changer," Gates wrote.

New research suggests that amyloid-beta (Aβ) oligomers and the vascular protein fibrinogen may, when forming a complex, contribute to Alzheimer's disease.

In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...

Time Course of Alzheimer's Disease Damage from the disease begins to accrue years or decades before any symptoms begin. A given individual presenting at age 70 might be expected to spend a decade ...

The Alzheimer’s Association encourages people to join its annual fundraiser on The Longest Day, with the proceeds going toward advancing research, treatment and care for the nearly 7 million ...

The team focused on Aβ42, a form of the amyloid beta with 42 amino acids that is commonly found in people with Alzheimer's disease. The researchers used three techniques in their work.